Cargando…

Metagenomics: The Next Culture-Independent Game Changer

A trend towards the abandonment of obtaining pure culture isolates in frontline laboratories is at a crossroads with the ability of public health agencies to perform their basic mandate of foodborne disease surveillance and response. The implementation of culture-independent diagnostic tests (CIDTs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Forbes, Jessica D., Knox, Natalie C., Ronholm, Jennifer, Pagotto, Franco, Reimer, Aleisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495826/
https://www.ncbi.nlm.nih.gov/pubmed/28725217
http://dx.doi.org/10.3389/fmicb.2017.01069
_version_ 1783247858544148480
author Forbes, Jessica D.
Knox, Natalie C.
Ronholm, Jennifer
Pagotto, Franco
Reimer, Aleisha
author_facet Forbes, Jessica D.
Knox, Natalie C.
Ronholm, Jennifer
Pagotto, Franco
Reimer, Aleisha
author_sort Forbes, Jessica D.
collection PubMed
description A trend towards the abandonment of obtaining pure culture isolates in frontline laboratories is at a crossroads with the ability of public health agencies to perform their basic mandate of foodborne disease surveillance and response. The implementation of culture-independent diagnostic tests (CIDTs) including nucleic acid and antigen-based assays for acute gastroenteritis is leaving public health agencies without laboratory evidence to link clinical cases to each other and to food or environmental substances. This limits the efficacy of public health epidemiology and surveillance as well as outbreak detection and investigation. Foodborne outbreaks have the potential to remain undetected or have insufficient evidence to support source attribution and may inadvertently increase the incidence of foodborne diseases. Next-generation sequencing of pure culture isolates in clinical microbiology laboratories has the potential to revolutionize the fields of food safety and public health. Metagenomics and other ‘omics’ disciplines could provide the solution to a cultureless future in clinical microbiology, food safety and public health. Data mining of information obtained from metagenomics assays can be particularly useful for the identification of clinical causative agents or foodborne contamination, detection of AMR and/or virulence factors, in addition to providing high-resolution subtyping data. Thus, metagenomics assays may provide a universal test for clinical diagnostics, foodborne pathogen detection, subtyping and investigation. This information has the potential to reform the field of enteric disease diagnostics and surveillance and also infectious diseases as a whole. The aim of this review will be to present the current state of CIDTs in diagnostic and public health laboratories as they relate to foodborne illness and food safety. Moreover, we will also discuss the diagnostic and subtyping utility and concomitant bias limitations of metagenomics and comparable detection techniques in clinical microbiology, food and public health laboratories. Early advances in the discipline of metagenomics, however, have indicated noteworthy challenges. Through forthcoming improvements in sequencing technology and analytical pipelines among others, we anticipate that within the next decade, detection and characterization of pathogens via metagenomics-based workflows will be implemented in routine usage in diagnostic and public health laboratories.
format Online
Article
Text
id pubmed-5495826
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54958262017-07-19 Metagenomics: The Next Culture-Independent Game Changer Forbes, Jessica D. Knox, Natalie C. Ronholm, Jennifer Pagotto, Franco Reimer, Aleisha Front Microbiol Microbiology A trend towards the abandonment of obtaining pure culture isolates in frontline laboratories is at a crossroads with the ability of public health agencies to perform their basic mandate of foodborne disease surveillance and response. The implementation of culture-independent diagnostic tests (CIDTs) including nucleic acid and antigen-based assays for acute gastroenteritis is leaving public health agencies without laboratory evidence to link clinical cases to each other and to food or environmental substances. This limits the efficacy of public health epidemiology and surveillance as well as outbreak detection and investigation. Foodborne outbreaks have the potential to remain undetected or have insufficient evidence to support source attribution and may inadvertently increase the incidence of foodborne diseases. Next-generation sequencing of pure culture isolates in clinical microbiology laboratories has the potential to revolutionize the fields of food safety and public health. Metagenomics and other ‘omics’ disciplines could provide the solution to a cultureless future in clinical microbiology, food safety and public health. Data mining of information obtained from metagenomics assays can be particularly useful for the identification of clinical causative agents or foodborne contamination, detection of AMR and/or virulence factors, in addition to providing high-resolution subtyping data. Thus, metagenomics assays may provide a universal test for clinical diagnostics, foodborne pathogen detection, subtyping and investigation. This information has the potential to reform the field of enteric disease diagnostics and surveillance and also infectious diseases as a whole. The aim of this review will be to present the current state of CIDTs in diagnostic and public health laboratories as they relate to foodborne illness and food safety. Moreover, we will also discuss the diagnostic and subtyping utility and concomitant bias limitations of metagenomics and comparable detection techniques in clinical microbiology, food and public health laboratories. Early advances in the discipline of metagenomics, however, have indicated noteworthy challenges. Through forthcoming improvements in sequencing technology and analytical pipelines among others, we anticipate that within the next decade, detection and characterization of pathogens via metagenomics-based workflows will be implemented in routine usage in diagnostic and public health laboratories. Frontiers Media S.A. 2017-07-04 /pmc/articles/PMC5495826/ /pubmed/28725217 http://dx.doi.org/10.3389/fmicb.2017.01069 Text en Copyright © 2017 Forbes, Knox, Ronholm, Pagotto and Reimer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Forbes, Jessica D.
Knox, Natalie C.
Ronholm, Jennifer
Pagotto, Franco
Reimer, Aleisha
Metagenomics: The Next Culture-Independent Game Changer
title Metagenomics: The Next Culture-Independent Game Changer
title_full Metagenomics: The Next Culture-Independent Game Changer
title_fullStr Metagenomics: The Next Culture-Independent Game Changer
title_full_unstemmed Metagenomics: The Next Culture-Independent Game Changer
title_short Metagenomics: The Next Culture-Independent Game Changer
title_sort metagenomics: the next culture-independent game changer
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495826/
https://www.ncbi.nlm.nih.gov/pubmed/28725217
http://dx.doi.org/10.3389/fmicb.2017.01069
work_keys_str_mv AT forbesjessicad metagenomicsthenextcultureindependentgamechanger
AT knoxnataliec metagenomicsthenextcultureindependentgamechanger
AT ronholmjennifer metagenomicsthenextcultureindependentgamechanger
AT pagottofranco metagenomicsthenextcultureindependentgamechanger
AT reimeraleisha metagenomicsthenextcultureindependentgamechanger